Go Deep
STAAR Surgical Company
STAAR Surgical Company Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 21,117 | 270.9 | 2.97 | 0.10 | 2,093.07 |
| Oct 2026 | 21,033 | 275.1 | 3.02 | 0.10 | 2,107.25 |
| Oct 2026 | 21,195 | 268.8 | 2.95 | 0.10 | 2,047.52 |
| Oct 2026 | 21,120 | 273.0 | 3.00 | 0.10 | 2,073.65 |
| Oct 2026 | 21,027 | 278.2 | 3.06 | 0.10 | 2,113.83 |
| Oct 2026 | 21,246 | 265.9 | 2.92 | 0.10 | 2,014.59 |
| Oct 2026 | 21,111 | 273.5 | 3.00 | 0.10 | 2,074.58 |
| Oct 2026 | 21,014 | 279.0 | 3.06 | 0.10 | 2,116.30 |
| Oct 2026 | 21,171 | 270.1 | 2.97 | 0.10 | 2,043.92 |
| Oct 2026 | 20,977 | 281.1 | 3.09 | 0.10 | 2,122.85 |
STAAR Surgical Company Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 93,535,000.0 | 93,522,000.0 | 57,801,000.0 | 94,732,000.0 |
| Net Profit | 8,058,000.0 | 5,206,000.0 | -18,309,000.0 | 8,884,000.0 |
| EPS | 0.2 | 0.1 | -0.4 | 0.2 |
STAAR Surgical Company Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 239,442,000.0 | 313,901,000.0 | 322,415,000.0 | 284,391,000.0 | — |
| Net Profit | -80,448,000.0 | -20,208,000.0 | 21,347,000.0 | 39,665,000.0 | — |
| EPS | -1.6 | -0.4 | 0.4 | 0.8 | — |
STAAR Surgical Company Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 451,678,000.0 | 509,524,000.0 | 488,692,000.0 | 418,818,000.0 | — |
| Total Liabilities | 107,494,000.0 | 112,189,000.0 | 102,738,000.0 | 82,706,000.0 | — |
| Total Equity | 344,184,000.0 | 397,335,000.0 | 385,954,000.0 | 336,112,000.0 | — |
Owes vs Owns
STAAR Surgical Company owed $0.23 for every $1 it owned in Jun 2026, up from $0.20 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.23× | 0.24× | 0.22× | 0.21× | 0.20× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
STAAR Surgical Company Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 41.5%Receivables 12.0%Inventory 12.3%Fixed assets (tangible) 22.8%Intangible assets 7.2%Other assets 4.2%
How it's funded — Dec 2025
Short-term debt 1.3%Long-term debt 7.2%Payables 2.6%Other liabilities 12.7%Shareholders' equity 76.2%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 187.5 | 230.5 | 220.7 | 211.6 |
| Receivables | 54.3 | 79.3 | 98.0 | 66.0 |
| Inventory | 55.5 | 43.3 | 35.1 | 24.2 |
| Fixed assets (tangible) | 102.9 | 121.8 | 101.4 | 81.5 |
| Intangible assets | 32.5 | 17.5 | 1.8 | 2.0 |
| Long-term investments | 0.0 | 0.0 | 11.7 | 13.9 |
| Other assets | 18.9 | 17.1 | 20.0 | 19.7 |
| Liabilities & equity | ||||
| Short-term debt | 5.9 | 3.9 | 4.4 | 3.7 |
| Long-term debt | 32.5 | 34.8 | 31.5 | 27.3 |
| Payables | 11.6 | 16.7 | 13.6 | 11.6 |
| Other liabilities | 57.6 | 56.7 | 53.3 | 40.1 |
| Shareholders' equity | 344.2 | 397.3 | 386.0 | 336.1 |
| Net tangible assets | 311.7 | 379.8 | 384.2 | 334.2 |
STAAR Surgical Company Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -34,230,000.0 | 15,725,000.0 | 14,594,000.0 | 35,715,000.0 | — |
| Investing Activities | 46,339,000.0 | -59,217,000.0 | 74,347,000.0 | -156,376,000.0 | — |
| Financing Activities | -4,555,000.0 | 5,724,000.0 | 7,415,000.0 | 8,297,000.0 | — |